SRx Health Solutions Receives NYSE American Notification for Equity Deficiency: A Threat to Its NYSE Listing
ByAinvest
Friday, Oct 17, 2025 8:02 am ET1min read
SRXH--
SRx Health Solutions was informed by NYSE American that it does not meet Section 1003(a)(ii) of the NYSE American Company Guide. This section requires a listed company to have stockholders' equity of $4 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The company has until November 13, 2025, to submit a plan detailing actions to meet these standards by the Plan Period Deadline of July 14, 2026.
The notice from NYSE American does not affect SRx Health's business operations or its reporting requirements with the U.S. Securities and Exchange Commission. The company has been advised to focus on regaining compliance to avoid potential listing delisting procedures.
SRx Health Solutions is subject to the procedures and requirements of Section 1009 of the Company Guide. The company must outline specific actions it will take to address the stockholders' equity issue and reverse the trend of reporting net losses in its upcoming fiscal years.
SRx Health Solutions' Chief Executive Officer, Kent Cunningham, stated, "We are committed to addressing this notice and taking the necessary steps to regain compliance with NYSE American's listing standards. We will work diligently to develop a comprehensive plan to meet the required stockholders' equity and improve our financial performance."
Investors and financial professionals are advised to monitor SRx Health Solutions' progress and future filings to assess the company's ability to meet the Exchange's listing standards and its overall financial health.
SRx Health Solutions received a notification from NYSE American that the company is not in compliance with the Exchange's listing standards due to a stockholders' equity deficiency of $4 million or more. The company has until November 13, 2025, to submit a plan to regain compliance by July 14, 2026. Receipt of the notice has no immediate effect on the listing or trading of SRx Health's common stock.
SRx Health Solutions (NYSE American: SRXH) has received a notice from NYSE American indicating non-compliance with the Exchange's listing standards due to a stockholders' equity deficiency. The company must submit a plan by November 13, 2025, to regain compliance by July 14, 2026. The notice does not immediately impact the listing or trading of SRx Health's common stock, according to a StockTitan report.SRx Health Solutions was informed by NYSE American that it does not meet Section 1003(a)(ii) of the NYSE American Company Guide. This section requires a listed company to have stockholders' equity of $4 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The company has until November 13, 2025, to submit a plan detailing actions to meet these standards by the Plan Period Deadline of July 14, 2026.
The notice from NYSE American does not affect SRx Health's business operations or its reporting requirements with the U.S. Securities and Exchange Commission. The company has been advised to focus on regaining compliance to avoid potential listing delisting procedures.
SRx Health Solutions is subject to the procedures and requirements of Section 1009 of the Company Guide. The company must outline specific actions it will take to address the stockholders' equity issue and reverse the trend of reporting net losses in its upcoming fiscal years.
SRx Health Solutions' Chief Executive Officer, Kent Cunningham, stated, "We are committed to addressing this notice and taking the necessary steps to regain compliance with NYSE American's listing standards. We will work diligently to develop a comprehensive plan to meet the required stockholders' equity and improve our financial performance."
Investors and financial professionals are advised to monitor SRx Health Solutions' progress and future filings to assess the company's ability to meet the Exchange's listing standards and its overall financial health.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet